Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma

Human Mutation

Volumn 11, Issue SUPPL 1, 1998, Pages

  Marsh, Debbie J ^a,b   Andrew, Scott D ^a   Learoyd, Diana L ^a,b   Pojer, Ruth ^a   Eng, Charis ^c,d   Robinson, Bruce G ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA;

ARTICLE; CODON; GENE MUTATION; HUMAN; HUMAN CELL; LEUKOCYTE; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; POINT MUTATION; PRIORITY JOURNAL; SOMATIC CELL GENETICS; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; CHEMISTRY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; MEDULLARY CARCINOMA; MUTATION; NUCLEOTIDE SEQUENCE; THYROID TUMOR;

BASE SEQUENCE; CARCINOMA, MEDULLARY; CODON; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DROSOPHILA PROTEINS; HUMANS; MUTAGENESIS, INSERTIONAL; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE DELETION; THYROID NEOPLASMS;

EID: 0032246147     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.1380110102     Document Type: Article

References (15)

1. Asai N, Iwashita T, Matsuyama M, Takahashi M (1995) Mechanism of activation of theret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 15:1613-1619.
2. Blaugrund JE, Johns MM, Eby YJ, Ball DW, Baylin SB, Hruban RH, Sidransky D (1994) RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet 3: 1895-1897.
3. Carlson KM, Dou S, Chi D, Scavarda N, Toshima K, Jackson CE, Wells SA, Jr, Goodfellow PJ, Donis-Keller H (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579-1583.
4. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JE Goodfellow E: Wells SAJ (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:8514356.
5. Dou .C., Chi D, Carlson KM, Moley JA, Wells SA, Donis-Keller H (1994) RET proto-oncogene mutations associated with sporadic cases of medullary thyroid carcinoma. Proceedings of the Fifth International Workshop on Multiple Endocrine Neoplasia Abstract 617:73.
6. Eng C, Smith DF: Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, Ponder BAJ (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic turnours. Hum Mol Genet 3:237-241.
7. Eng C, Smith DF: Mulligan LM, Healey CS, Zvelebil MJ, Stonehouse TJ, Ponder MA, Jackson CE, Waterfield MD, Ponder BAJ (1995) A novel point mutation in the tyrosine kinase domain of theRET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 10:509-513.
8. Hofstra RM, Landsvater RM, Ceccherini 1, Stulp W Stelwagen T, Luo Y, Pasini B, Hoppener JW, van Amstel HK, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376.
9. Komminoth F: Kunz EK, Matiasguiu X, Hiort 0, Christensen G, Colomer A, Roth J, Heitz PU (1995) Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer 76:479489.
10. Marsh DJ, Robinson BG, Andrew S, Richardson A-L, Pojer R, Schnitzler M, Mulligan LM, Hyland VJ (1994) A rapid screening method for the detection ofmutations in theRETproto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. Genomics 23:477479.
11. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458460.
12. Mulligan LM, Marsh DJ, Robinson BG, Schuffenecker I, Zedenius J, Lips CJM, Gagel RF, Takai SI, Noll WW, Fink M, Raue F, Lacroix A, Thibodeau SN, Frilling A, Ponder BAJ, Eng C, for the InternationalRETMutation Consortium (1995) Genotype-Phenotype correlation in MEN 2: Report of the IntemationalRETmutation consortium. J Intern Med 238:343-346.
13. Santoro M, Carlomagno F, Romano A, Bottaro DF: Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, di Fiore PP (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267:381-383.
14. Wright DK, Manos M (1990) Sample preparation from parafinembedded tissues. In Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds): PCR Protocols: A Guide to Methods and Application. San Diego: Harcourt, pp 153-158.
15. Zedenius J, Larsson C, Bergholm U, Bovee J, Svensson A, Hallengren B, Grimelius L, Backdahl M, Weber G, Wallin G (1995) Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. J Clin Endocrinol Metab 80:3088-3090.